Detalhe da pesquisa
1.
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
N Engl J Med
; 390(15): 1359-1371, 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38631003
2.
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma.
Oncologist
; 29(2): 142-150, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37589219
3.
Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
N Engl J Med
; 385(8): 683-694, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34407342
4.
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 23(9): 1133-1144, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36055304
5.
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
PLoS Med
; 18(3): e1003415, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33657114
6.
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon.
Adv Exp Med Biol
; 995: 97-125, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28321814
7.
[Recommendations for the management of pancreatic cancer type adenocarcinoma: A consensus statement reached during the 2015 Latin American Symposium on Gastroenterological Oncology]. / Recomendaciones sobre el manejo del cáncer de páncreas tipo adenocarcinoma en Latinoamérica: Reunión del Consenso del Simposio Latinoamericano de Gastroenterología Oncológica (SLAGO) y de la Asociación Ibero Latinoamericana de Terapia Radiante (ALATRO), Viña del Mar, Chile 2015.
Rev Med Chil
; 144(10): 1305-1318, 2016 Oct.
Artigo
em Espanhol
| MEDLINE | ID: mdl-28074986
8.
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non-Small-Cell Lung Cancer in CheckMate 227.
J Clin Oncol
; 41(6): 1200-1212, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36223558
9.
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1.
J Thorac Oncol
; 18(8): 1055-1069, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37146754
10.
Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience.
J Pers Med
; 12(2)2022 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35207683
11.
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations.
JCO Glob Oncol
; 8: e2200123, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35994695
12.
Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety.
Ecancermedicalscience
; 15: 1168, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33680082
13.
Triple-negative breast cancer: the reality in Chile and in Latin America.
Ecancermedicalscience
; 13: 893, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792810
14.
Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer.
Onco Targets Ther
; 11: 7295-7300, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30425520
15.
The current situation for gastric cancer in Chile.
Ecancermedicalscience
; 10: 707, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105078
16.
Hepatocellular carcinoma in identical twins in Chile: case report.
Ecancermedicalscience
; 10: 708, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-28105079
17.
Recomendaciones sobre el manejo del cáncer de páncreas tipo adenocarcinoma en Latinoamérica: Reunión del Consenso del Simposio Latinoamericano de Gastroenterología Oncológica (SLAGO) y de la Asociación Ibero Latinoamericana de Terapia Radiante (ALATRO), Viña del Mar, Chile 2015 / Recommendations for the management of pancreatic cancer type adenocarcinoma: A consensus statement reached during the 2015 Latin American Symposium on Gastroenterological Oncology
Rev. méd. Chile
; 144(10): 1305-1318, oct. 2016.
Artigo
em Espanhol
| LILACS | ID: biblio-845445